webdesign naloo

Search
Print page-AA+AContactHome

Disease Database

last  update 08.05.2013

Genes and loci reported throughout the years


annual listing                                                                   
compiled listing

Genes and loci reported throughout the years - annual listing

Click on the graphics to download a high resolution copy in tif formate.

Albinism

Bardet Biedl Syndrome

Colour Vision Defects

Cone + Cone Rod Dystrophies

Congenital Stationary Night Blindness

Incontinentia Pigmenti

Leber`s Congenital Amaurosis
and other Early Onset Severe Retinal Dystrophies

Other Diseases

26.02.04

09.05.07

10.03.04

14.03.10

14.03.10

11.03.04

30.09.12

08.05.04

top

Chromosome 1 

CHS1, q42.1-2, LYST BBS16, q34-q44, SDCCAG8 ACHM4, p13, GNAT2

CRD, p21-13, ABCA4

CRD, q12-24

CORD8, q12-24

CORD10, q22, SEMA4A

LCA9, p36.22, NMNAT1

LCA2, p31, RPE65

LCA8, q31-32.1, CRB1

LCA12, q32, RD3

FRFB, p36.13-12, PLA2G5

top

Chromosome 2

BBS15, p15, C2ORF86

BBS5, q31

ACHM2, q11.2, CNGA3 Oguchi, q37, SAG

LCA, p13.1, ALMS1

LCA, q11.2, CNGA3

LCA16, q37.1, KCNJ13

top

Chromosome 3

HPS3, q24, HPS3 BBS17, p21.31, LZTFL1


BBS3, p13-12, ARL6

CSNB Nougaret type, p22, GNAT1

CSNB RHO-type, q21-24, RHO

LCA, q11.2, IQCB1

top

Chromosome 4

BBS7, q27, BBS2L1

BBS12, q27, FLJ35630

CSNB1F, p25, LRIT3

CSNB3, p16.3, PDE6B

LCA14, q31.2, LRAT ABL, q22-24, MTP

top

Chromosome 5

OCA4, p13, MATP

HPS2, q13, ADTB3

CSNB1B, adCSNB, q35, GRM6

top

Chromosome 6

HPS7, p22.3 DTNBP1

OAR, q13-15

CRD, p21.1, GUCA1A

COD/CORD, p21.1-12.2

CORD7, q13-15, RIM1

RCD1, q25-26

LCA15, p21.3, TULP1

LCA5, q14, C6ORF152

top

Chromosome 7

BBS9, p14, PTHB1 Tritanopia, q31.3-32, OPN1SW LCA11, q31.3, IMPDH1

top

Chromosome 8

ACHM3, q21.1-22.1, CNGB3

CORD9, p11-q11, ADAM9

CORD16, q22, C8orf37


LCA11, q22.1, GDF6

top

Chromosome 9

OCA3, p23, TYRP1

BBS11, q33.1, TRIM32

MORM, q34

COD, p24, KCNV2 Hypomelanosis of Ito, q33-ter

top

Chromosome 10

OCA, q22.3, C10ORF11

HPS1, q23, ep

HPS6, q24-32, ru

ACHM5, q24, PDE6C

CORD15, q23.1-23.2, PCDH21

COD4, q24, PDE6C

COD4, q31.3, PDE6C

RNANC, q21

MCMR, q23-33, KIF11

GA, q26, OAT

top

Chromosome 11

HPS5, p15-13, ru2

OCA1, q14.3, Tyr
BBS1, q13, BBS2L2 CSNB2B, q13.1, CABP4

LCA, q13, CABP4

LCA, q13.5, MyoVIIa

MCOP5, NNOS2, q23.3, MFRP

top

Chromosome 12

BBS10, q, FLJ23560/ C12orf58

BBS14, q21.3, CEP290

RCD3B/ACHM6, p12.3, PDE6H CRD, p13.3, CACNA2D4 LCA10, q21.3, CEP290 CODA1, q13.13-14.3

top

Chromosome 13

Oguchi disease, q34, GRK1 RB1, q14.2, RB1

top

Chromosome 14

BBS8, q32.1, TTC8 ACHM1, CRD, q11, RPGRIP MCOPS5. 14q21-22, OTX2

LCA6, q11, RPGRIP

LCA13, q23.3, RDH12

LCA3. q31.3, SPATA7

top

Chromosome 15

HPS9, p22.1, PLDN

OCA2, OA3, q11.2-12, P-gene

GS, q21, RAB27A

BBS4, q22.3-23, BBS4

arCSNB, 15q13-14, SLC24A1

CSNB1C, 15q13-14, TRPM1

Hypomelanosis of Ito, q11-13

top

Chromosome 16

OCA5, q24.3, MC1R BBS2, q13, BBS2 EOSRD, q23, ADAMTS18

top

Chromosome 17

BBS13, q22, MKS ADCD, p13

CORD5, p13-12, PITPNM3

CORD6, p13-12, GUCY2D

CRD, q

CORD4, q

CORD2, q11.2, AIPL1

CRD, q11.2, HRG4

CSNB1E, q12, GPR179 LCA1, p13, GUCY2D

LCA4, p13.1, AIPL1

top

Chromosome 18

CORD1, q21.1-21.3

top

Chromosome 19

CORD2, q13.3, CRX LCA7, q13.3, CRX

top

Chromosome 20

BBS6, p12, MKKS HARP, p13, PANK2

top

Chromosome 21

top

Chromosome 22

HPS4, q11.2-12.2, le

top

Chromosome X

OA1, p22.3-22.2, GPR143

ADFN, q26.3-27.1

CORDX1 (RP15), p22.13-22.11

COD1, p11.4, RPGR

COD, p11.4 - q13.1

CORDX3, p11.23, CACNA1F

XLPCD2, q27

COD2, q28, OPNMW, OPNLW
CSNB2, AIED (OA2) , p11.23, CACNA1F

CSNB1, p11.3, NYX
Hypomelanosis of Ito, p11

IP1, p11.2,

IP2, q28, IKBKG
CHM, q21.2, REP1

top

Mitochondrial





top

Remarks 

Triallelic Inheritance


top

Summary 

20 Loci
17 Genes id.
18 Loci
16 Genes id.
10 Loci
8 Genes id.
31 Loci
20 Genes id.
14 Loci
13 Genes id.
5 Loci
1 Genes id.
25 Loci
  24 Genes id.
11 Loci
8 Genes id.

top

Table 2 

Neuronal Ceroid Lipofuscinosis

Optic Atrophy

Retinal and Macular Dystrophies

Retinitis Pigmentosa

Syndromes

Usher Syndrome

Vitreoretinopathies

Age-related Macular Dystrophies

26.02.04

09.05.07

09.05.13

09.05.13

14.03.10

11.03.04

14.03.10

10.03.04

top

Chromosome 1 

CLN1, CLN4, p32, PPT HMSN6, q36.22, MFN2
RP59, p36.11, DHDDS

RP32, p21.2-13.3

RP19, p21-13, ABCA4

RP18, q13-21, HPRP3

RP35, q22, SEMA4A

RP20, q31,RPE65

RP12, RPCLD, q31-32.1, CRB1

RP39, q41, USH2A

SLSN4, p36, NPHP4

STL2, p21.1, COL11A1

AXPC1, q31-32,
FLVCR1

SLSN7, q34-44, SDCCAG8

USH2A, q41, USH2A ARMD2, p22-21, ABCA4

ARMD1, q24-25, HMCN1

ARMD4, q32, CFH

top

Chromosome 2


MLTV, DHRD, p16, EFEMP1
RP54, p22.2-24.1, C2ORF71

RP58, p22.3-24.1, ZNF513

RP28, p15-11, FAM161A

RP33, q11.2, SNRNP200, ASCC3L1


RP38, q14, MERTK

RP26, q31.2-32.3, CERKL

RP47, q37,SAG

ALMS, p13, ALMS1

CRD + Ameliogenesis, q11, CNNM4

SLSN1, JBTS4, q13, NPHP1

JBTS14, q33, TMEM237

JBTS11, 2q24.3, TTC21B

SVD, q37, KCNJ13

top

Chromosome 3

OPA1, q28, OPA1
RPA, q21-24, RHO
RP5, q

RP55, q11.2, ARL6

RP56, q12.2-12.3, IMPG2

ARRP, q21-24, RHO

RP4, q21-24, RHO

RP61, q25, CLRN1
ADCAII (SCA7), p21.1-12,

HERNS (CRV, HRV), q21.1-3, TREX1

SLSN5, q21.1, IQCB1

SLSN3, q22, NPHP3
USH2B, p24.2-23, SLC4A7

USH3, q21-25, Clarin-1

top

Chromosome 4


STGD4
MCDR2, p16, PROM1

BCD, q35.2, CYP4V2
RP41, p16, PROM1

RP40, p16.3, PDE6B

RP49, p12-cen, CNGA1

RP29, q32-34,

DIDMOAD, p16, WFS1

NPHP13, p14, WDR19



JBTS9, MKS6, p15.3, CC2D2A

WFS2, q22 - q24, CISD2


ARMD, q35.1, TLR3

top

Chromosome 5


MCDR3, p13.1-15.33,

BSMD, q21.2-33.2,
RP43, q31.2-34, PDE6A USH2C, q14.3-21.3, VLGR1 WGN1, q13-14, VCAN, CSPG2

top

Chromosome 6


RPA, Retinal pattern dystrophy, p12, PRPH2

BCAMD, p12.3-q16, IMPG1

PBCRA, q11-16.2

adRD,p21.1,GUCA1B

adMD, q14, ELOVL4

STGD3, q14, ELOVL4

Dominant drusen with macular dystrophy, q14

autosomal dominant Stargardt-like Macular Dystrophy, q16,

MCDR1, q16,
RP48, p21.1, GUCA1B

RP62, p24.2, MAK

RP14, p21.3, TULP1

RP7, digenic RP, p12, PRPH2

RP25, q12.4, EYS

RP63, q23
North Carolina Macular Dystrophy segregating with progressive sensorineural deafness, 6,

STL3, q13, COL9A1

Refsum Disease, adult 2, q22-24, PEX7

JBTS3, q23.3, AHI1

ARMD, p12.3, C2

ARMD, p12.3, CFB

top

Chromosome 7


DCMD, p21-15 RP42, p15.3, KLHL7

RP9, p14, PIM1K

RP10, q31.3, IMPDH

Refsum Disease, q21-22, PEX1

JBTS15, q32.2, CEP41

DFEVR, q31, TSPAN12

top

Chromosome 8

OPA6 (ROA), q21-22 OMD, q24, RP1L1

VMD1, q24

RP1, q12-13, RP1

RP64, q22, C8orf37

Refsum Disease, infantile, q21.1, PXMP3

Ataxia and Retinitis Pigmentosa with isolated Vitamin E Deficiency, q13.1-13.3, TTPA

JBTS6, q24, TMEM67



top

Chromosome 9


RP31, p22-13, TOPORS

RP21, q34-ter
JBTS1, q34.3, INPP5E

SLSN, q31, NPHP2
USH2D, q32-34, Whirlin ARMD10, q32-33, TLR4

top

Chromosome 10


Fundus Xerophthalmicus, q24, RBP4 ARRP, q11, RBP3

ARRP, q23.1-23.2, PCDH21

ADRP, RP44, q23, RGR
Refsum Disease, adult, pter-11.2, PAHX

Refsum Disease, adult with increased pipecolicacidemia, pter-11.2,

USH1K, p11.21-q21.1

USH1F, q11.2-21, PCDH15

USH1D, q21-22, CDH23

USH1D/F digenic, q11.2-22, CDH23, PCDH15

Modifying
q24.31,
PDZD7

ARMD5, q11, ERCC6

ARMD7, q26, HTRA1

ARMD8, q26, LOC387715

top

Chromosome 11

CLN2, p15.5, CLN2 OPA7, q14.1-21, TMEM126A AA, p15, TEAD1

VMD2, ARB, ADVIRC , q12-13.1, BEST1

L-ORD, LOMD , q23.3, CTRP5
RP50, q12-13.1, BEST1

ADRP, RP digenic, q13, ROM1

JBTS2, q12.2, TMEM216
JBTS16, q12.2, TMEM138


Mirophthalmia with posterior cataract, q23

USH1C, p14.3, USH1C

USH1B, q13.5, MyoVIIa
EVR3, p12-13

VRNI, q13

EVR1, q13-23, FZD4

EVR4, q13.2, LRP5

top

Chromosome 12


FA, q13-14, RDH5

STL, q13.11-13.13, COL2A1

JBTS5, SLSN6, MKS4 q31, CEP290

Autosomal Dominant Rhegmatogenous Retinal Detachment, q13.11-13.13, COL2A1

JBTS13, q24.11, TCTN1


WGN2, q13.11-13.2, COL2A1

top

Chromosome 13

CLN5, q21.1-32, CLN5
STGD2, q34 ARRP, q34, GRK1

top

Chromosome 14


MCDR4, q RP27, ADRP/CMO, RP,si, q11, NRL

RP16, q11-13.1

RP53, q23.3, RDH12

RP51, q32.1, TTC8
USH1A, q32, ARMD3, q32.12, FBLN5

top

Chromosome 15

CLN6, q21-23, CLN6
ESCS, q23, NR2E3

NFRCD, RPA, BRD, q26, RLBP1
ARRP, q26, RLBP1

Severe Mental Retardation, Spasticity, and Tapetoretinal Degeneration, q24

JBTS12, q26.1, KIF7

USH1H, q22-23

USH1J, q23-25.1,
CIB2


top

Chromosome 16

CLN3 (JCNL), p12.1, CLN3 OPA8, q21-22 PXE, p13.1, ABCC6

HJMD, q22.1, CDH3
RP22, p12.3-12.1

RP45, p13, CNGB1

RP + skelettal abnormalities, q13.3, GNGPT

FHASD, q23.2-24.2

MCDC1, q22, CHST6

KNO2, q23, ADAMTS18


JBTS, q31, RPGRIP1L



top

Chromosome 17


CACD, p13-12

SPD, q24, RGS9
RP13, p13.3, PRPC8

RP36, q22, PRCD

RP17, q23, CA4

RP30, q25, FSCN2

RP57, q25.3, PDE6G
MKS1, q22, MKS1 USH1G, q24-25, SANS

top

Chromosome 18

OPA4, q12.2-3


top

Chromosome 19

OPA3, q13.2-3, OPA3 MCDR5, q13.31-32

SPD, q24, R9AP
ADRP, q13.3, CRX

RP11, q13.4, PRKCG

RP11a, q13.4, PRPF31

ARMD6, p13.3, QRX

ARMD9, p13.3-2, C3

top

Chromosome 20


RP46, p13, IDH3B

RP60, q13.33, PRPF6
AGS, p12, JAG1

top

Chromosome 21



USH1E, q21,

top

Chromosome 22

OPA5, q12.3 SFD, q12-13.2, TIMP3


top

Chromosome X

OPA2, p11.4-11.21 CORD3 (RP15) , p22.13-22.11, RPGR

PRD, p11.3-11.23,

RS, p22.2, XLRS1
RP23, p22,

RP3, p21.1, RPGR

RP6, p21.3-21.2,

RP2, p11.3-11.22, RP2

RP24, q26.2-27.2

RP34, q28
ND, p11.4, NDP

OCRL, q25-26, OCRL1

JBTS10, p22.3-2, CXORF5, OFD1

MTS, p22.1, TIMM8A

XEFVR, p11.3-11.23, NDP

top

Mitochondrial

LHON

KS

NARP syndrome, ATPase6

Pigmentary Retinopathy and Sensorineural Deafness, MTTH

Wolfram Syndrome (Diabetes insipidus, diabetes mellitus, optic atrophy and deafness), mitochondrial 11778

MELAS, A3243G,
MTTL1

MERF, 15975,
MTTP

Sensorineural Deafness with RP, MTTS2

top

Remarks



digenic inheritance

top

Summary

6 Loci
5 Genes id.
10 Loci
5 Genes id.
48 Loci
27 Genes id.
73 Loci
57 Genes id.
60 Loci
50 Genes id.
17 Loci
12 Genes id.
9 Loci
7 Genes id.
13 Loci
13 Genes id.